Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Plasticity of Crystalline CK2α′ Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity
Dirk Lindenblatt, Violetta Applegate, Anna Nickelsen, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 1302-1312
Closed Access | Times Cited: 22

Showing 22 citing articles:

CK2 Regulation: Perspectives in 2021
Scott E. Roffey, David W. Litchfield
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1361-1361
Open Access | Times Cited: 68
Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6356-6389
Closed Access | Times Cited: 46
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects
Yijia Chen, Yuxi Wang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2257-2281
Closed Access | Times Cited: 41
Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket
Alexandre Bancet, Rita Frem, Florian Jeanneret, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108903-108903
Open Access | Times Cited: 7
Recent Advances in the Discovery of CK2 Inhibitors
Mustafa A. Al-Qadhi, Tawfeek Ahmed Ali Yahya, Hala B. El‐Nassan
ACS Omega (2024) Vol. 9, Iss. 19, pp. 20702-20719
Open Access | Times Cited: 6
Exploring the biological potential of the brominated indenoindole MC11 and its interaction with protein kinase CK2
Christelle Marminon, Christian Werner, Alexander Gast, et al.
Biological Chemistry (2025)
Closed Access
Scaffold hopping and sidechain modification from a flavone scaffold lead to discovery of potent, selective CK2A2 inhibitors with favorable properties for CNS activity
James K. Tucker, Ioana I.N. DaSilva, Fred H. Gage
Bioorganic & Medicinal Chemistry (2025), pp. 118196-118196
Closed Access
Picomolar Bivalent Inhibitors of Protein Kinase Ck2 Active Against Β-Coronavirus Replication
D. Grenier, Domingo Sabina Molina, Muriel Gelin, et al.
(2025)
Closed Access
Regulation of cancer progression by CK2: an emerging therapeutic target
Shakeel Hussain, Yilei Guo, Yu Huo, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 3
Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting
Francesco Greco, Andreas Krämer, L M Wahl, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116672-116672
Open Access | Times Cited: 2
CK2 Chemical Probes: Past, Present, and Future
Han Wee Ong, David H. Drewry, Alison D. Axtman
Kinases and Phosphatases (2023) Vol. 1, Iss. 4, pp. 288-305
Open Access | Times Cited: 5
Discovery and Exploration of Protein Kinase CK2 Binding Sites Using CK2α′Cys336Ser as an Exquisite Crystallographic Tool
Christian Werner, Dirk Lindenblatt, Kaido Viht, et al.
Kinases and Phosphatases (2023) Vol. 1, Iss. 4, pp. 306-322
Open Access | Times Cited: 4
Protein Kinase CK2α’, More than a Backup of CK2α
Mathias Montenarh, Claudia Götz
Cells (2023) Vol. 12, Iss. 24, pp. 2834-2834
Open Access | Times Cited: 4
Analyzing the interactome of human CK2β in prostate carcinoma cells reveals HSP70 ‐1 and Rho guanin nucleotide exchange factor 12 as novel interaction partners
Anna Nickelsen, Claudia Götz, Florian Lenz, et al.
FASEB BioAdvances (2023) Vol. 5, Iss. 3, pp. 114-130
Open Access | Times Cited: 3
Structure-Guided Discovery of Adenosine Triphosphate-Competitive Casein Kinase 2 Inhibitors
Shivani Patel, Vivek K. Vyas, Manmohan Sharma, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 11, pp. 987-1014
Closed Access | Times Cited: 2
Scoping Pleiotropy of CK2 in Musculoskeletal Disorders for a Novel Targeting Approach
Venu Pandit, Kailey DeGeorge, Anja Nohe
Kinases and Phosphatases (2024) Vol. 2, Iss. 1, pp. 43-66
Open Access
Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting
Francesco Greco, Andreas Krämer, L M Wahl, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Synthesis and Evaluation of Chemical Linchpins for Highly Selective Ck2α Targeting
Francesco Greco, Andreas Krämer, L M Wahl, et al.
(2024)
Open Access
A comprehensive review on the dynamics of protein kinase CK2 in cancer development and optimizing therapeutic strategies
Muhammad Usman Ghani, Junbo Shi, Yi Du, et al.
International Journal of Biological Macromolecules (2024), pp. 135814-135814
Closed Access
Scoping Multiformity of CK2 in Musculoskeletal Disorders for a Novel Approach of Targeting
Venu Pandit, Kailey DeGeorge, Anja Nohe
(2023)
Open Access | Times Cited: 1
Competition between electrostatic interactions and halogen bonding in the protein–ligand system: structural and thermodynamic studies of 5,6-dibromobenzotriazole-hCK2α complexes
Maria Winiewska‐Szajewska, H. Czapinska, Magdalena Kaus‐Drobek, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
AB668, a novel highly selective protein kinase CK2 inhibitor with a distinct anti-tumor mechanism as compared to CX-4945 and SGC-CK2-1
Alexandre Bancet, Rita Frem, Florian Jeanneret, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1

Scroll to top